Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article atai Life Sciences Makes $50m Investment in Beckley Psytech

atai Life Sciences Makes $50m Investment in Beckley Psytech

  • Post published:January 4, 2024
  • Post category:Analysis/News
Read more about the article Kentucky’s $42m Ibogaine Funding Appears Dead in the Water

Kentucky’s $42m Ibogaine Funding Appears Dead in the Water

  • Post published:December 29, 2023
  • Post category:Analysis/News
Read more about the article Psychedelic Bulletin #152: Policy and Business Updates

Psychedelic Bulletin #152: Policy and Business Updates

  • Post published:December 22, 2023
  • Post category:Psychedelic Bulletin
Read more about the article Psychedelic Research Bulletin: November 2023

Psychedelic Research Bulletin: November 2023

  • Post published:December 19, 2023
  • Post category:Psychedelics Research Review
Read more about the article Natural Medicine Advisory Bulletin #6: November 2023

Natural Medicine Advisory Bulletin #6: November 2023

  • Post published:December 15, 2023
  • Post category:Colorado Natural Medicine Advisory Bulletin
Read more about the article Pα+ Psychedelic Bulletin #151: Psilocybin for BDII, ACNP Readouts, Methylone for PTSD, and More Psychedelic Drug Dev. News

Pα+ Psychedelic Bulletin #151: Psilocybin for BDII, ACNP Readouts, Methylone for PTSD, and More Psychedelic Drug Dev. News

  • Post published:December 14, 2023
  • Post category:Psychedelic Bulletin/Pα+
Read more about the article BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD

BREAKING: MAPS PBC Files New Drug Application for MDMA-Assisted Therapy for PTSD

  • Post published:December 12, 2023
  • Post category:Analysis/News
Read more about the article The Psychedelic News Feed: Nov 6 – Dec 10, 2023

The Psychedelic News Feed: Nov 6 – Dec 10, 2023

  • Post published:December 11, 2023
  • Post category:Psychedelic News Feed Archive
Read more about the article Pα+ Library: Bifurcated Scheduling

Pα+ Library: Bifurcated Scheduling

  • Post published:December 6, 2023
  • Post category:Library/Pα+
Read more about the article Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates

Pα+ Psychedelic Bulletin #150: Drug Development and Research Updates

  • Post published:November 29, 2023
  • Post category:Psychedelic Bulletin/Pα+

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More